îæ€çŽ¢
îæ€çŽ¢
î
Galmed Pharmaceuticals Ltd
GLMDîãŠã©ãããªã¹ãã«è¿œå
3.625USD
+0.125+3.57%
çµå€Â 09-09 16:00ïŒETïŒ
29.94Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
GLMD ã¢ããªã¹ãæšå¥šãã¬ã³ã
ä»æãGLMDã¯0件ã®ãè²·ããã1件ã®ãäžç«ïŒããŒã«ãïŒãã0件ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããGLMDã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯0.000ã§ãã
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
GLMD åæ¥è æ¯èŒã¢ããªã¹ãè©äŸ¡
æŽæ°æå»: Oct 20, 2026äŒç€Ÿå
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
ã¢ããªã¹ã
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Insmed Inc
INSM
7
18
0
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
Biontech SE
BNTX
4
12
8
0
0
24
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
Cytokinetics Inc
CYTK
5
16
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
財åäºæž¬
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS -2.860ã«ç¶ããGLMDã®FY2026Q3ã®EPSã¯-3.060ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
äºæž¬å€
-4.08
-3.04
-3.12
-3.06
-3.17
å®çžŸå€
-0.80
-2.32
-2.86
--
--
ãµãã©ã€ãº
+80.37%
+23.74%
+8.34%
--
--
ãããã質å
Galmed Pharmaceuticals LtdGLMD ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -2.86 ã§ããããGalmed Pharmaceuticals LtdGLMD ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -2.32 ã§ããã次ã®ååæã® EPS 㯠USD -3.06 ãšäºæ³ãããŸãã
Galmed Pharmaceuticals Ltd ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î1 ã¢ããªã¹ãã«ãã Galmed Pharmaceuticals Ltd æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠signal_hold ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« Galmed Pharmaceuticals Ltd ã®æ ªäŸ¡ã¯ signal_hold ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã